Pharmaceuticals by operating margin
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Royalty Pharma leads the 43 pharmaceuticals ranked by operating margin, at 65.6%, ahead of PTC Therapeutics (50.1%) and United Therapeutics (46.9%). Figures as of 18 Nov 2026, 12:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 43
- First
- Royalty Pharma65.6%
- Median
- 12.5%
- Combined market value
- SAR 19.35T
- Countries
- 10
- Not ranked
- 18no operating margin on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Operating margin ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Royalty PharmaRPRX · Health Care | 65.6% | SAR 148.1B | SAR 257.62 | 0.23% up | 78% up | ||
| 2 | PTC TherapeuticsPTCT · Health Care | 50.1% | SAR 18.9B | SAR 226.41 | 1.00% down | 20% down | ||
| 3 | United TherapeuticsUTHR · Health Care | 46.9% | SAR 93.3B | SAR 2,190.96 | 0.64% down | 23% up | ||
| 4 | Novo NordiskNVO · Health Care | 41.3% | SAR 672.9B | SAR 152.67 | 2.16% down | 17% down | ||
| 5 | Vertex PharmaceuticalsVRTX · Health Care | 34.8% | SAR 508B | SAR 2,003.78 | 0.67% down | 27% up | ||
| 6 | NovartisNVS · Health Care | 32.4% | SAR 1.13T | SAR 596.90 | 0.67% down | 25% up | ||
| 7 | GenmabGMAB · Health Care | 28.6% | SAR 120.2B | SAR 194.90 | 0.76% up | 70% up | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | 24.9% | SAR 371.6B | SAR 3,592.56 | 0.56% up | 36% up | ||
| 9 | AbbVieABBV · Health Care | 24.6% | SAR 1.94T | SAR 1,098.37 | 0.59% down | 26% up | ||
| 10 | GSKGSK · Health Care | 24.3% | SAR 370.2B | SAR 184.70 | 2.32% down | 6% up | ||
| 11 | AstraZenecaAZN · Health Care | 23.4% | SAR 1.06T | SAR 683.69 | 0.95% down | 2% up | ||
| 12 | TG TherapeuticsTGTX · Health Care | 20.0% | SAR 35.6B | SAR 235.23 | 0.08% down | 107% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | 18.2% | SAR 680.2B | SAR 392.77 | 2.55% down | 17% down | ||
| 14 | AlkermesALKS · Health Care | 17.2% | SAR 28.6B | SAR 170.48 | 2.32% down | 58% up | ||
| 15 | GrifolsGRFS · Health Care | 16.5% | SAR 22B | SAR 32.37 | 1.15% down | 1% up | ||
| 16 | Ligand PharmaceuticalsLGND · Health Care | 15.3% | SAR 22B | SAR 1,102.08 | 2.62% down | 43% up | ||
| 17 | Dr. Reddy's LaboratoriesRDY · Health Care | 15.0% | SAR 46.2B | SAR 55.48 | 0.61% up | 5% up | ||
| 18 | SanofiSNY · Health Care | 14.5% | SAR 428.1B | SAR 178.29 | 1.78% down | 4% down | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | 13.5% | SAR 78.6B | SAR 587.03 | 2.02% down | 66% down | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | 13.1% | SAR 27.6B | SAR 79.22 | 0.52% down | 83% up | ||
| 21 | BioMarin PharmaceuticalBMRN · Health Care | 12.7% | SAR 42.5B | SAR 219.47 | 0.90% up | 11% up | ||
| 22 | Teva Pharmaceutical IndustriesTEVA · Health Care | 12.5% | SAR 186.5B | SAR 159.87 | 0.12% up | 74% up | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | 11.9% | SAR 22.8B | SAR 161.26 | 2.76% down | 10% up | ||
| 24 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.4% | SAR 28B | SAR 356.76 | 0.93% up | 126% up | ||
| 25 | BeOne MedicinesONC · Health Care | 8.37% | SAR 177.1B | SAR 1,550.14 | 0.48% up | 17% up | ||
| 26 | Corcept TherapeuticsCORT · Health Care | 5.88% | SAR 28.8B | SAR 262.83 | 1.23% up | 8% down | ||
| 27 | Takeda PharmaceuticalTAK · Health Care | 0.14% | SAR 259.3B | SAR 81.17 | 0.23% up | 54% up | ||
| 28 | Mirum PharmaceuticalsMIRM · Health Care | -4.25% | SAR 22.5B | SAR 344.90 | 0.40% up | 31% up | ||
| 29 | Jazz PharmaceuticalsJAZZ · Health Care | -10.1% | SAR 58B | SAR 902.90 | 0.39% up | 37% up | ||
| 30 | Travere TherapeuticsTVTX · Health Care | -12.8% | SAR 18.4B | SAR 191.68 | 2.82% up | 44% up | ||
| 31 | Legend BiotechLEGN · Health Care | -13.3% | SAR 11.7B | SAR 60.43 | 0.75% up | 42% down | ||
| 32 | ViatrisVTRS · Health Care | -18.6% | SAR 87.9B | SAR 76.71 | 1.40% down | 96% up | ||
| 33 | Ascendis PharmaASND · Health Care | -18.9% | SAR 66.7B | SAR 1,017.23 | 0.20% down | 28% up | ||
| 34 | Axsome TherapeuticsAXSM · Health Care | -26.1% | SAR 26.8B | SAR 509.95 | 0.77% down | 7% down | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -31.3% | SAR 36.8B | SAR 1,582.88 | 0.46% down | 24% down | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | -40.4% | SAR 16.8B | SAR 101.13 | 3.75% down | 64% down | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | -101% | SAR 30.3B | SAR 437.40 | 8.49% up | 13% up | ||
| 38 | BridgeBio PharmaBBIO · Health Care | -104% | SAR 56.1B | SAR 288.08 | 0.72% down | 17% up | ||
| 39 | InsmedINSM · Health Care | -206% | SAR 100.3B | SAR 457.10 | 0.83% down | 40% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | -344% | SAR 30.5B | SAR 467.64 | 0.13% down | 46% up | ||
| 41 | CytokineticsCYTK · Health Care | -695% | SAR 27B | SAR 193.74 | 2.86% down | 20% down | ||
| 42 | Roivant SciencesROIV · Health Care | -6236% | SAR 105.2B | SAR 145.20 | 0.26% up | 90% up | ||
| 43 | Dianthus TherapeuticsDNTH · Health Care | -8739% | SAR 18.4B | SAR 326.26 | 2.87% down | 113% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Operating margin is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Banks and insurers report no operating income and are not ranked on it. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 18 companies have no operating margin on file and are not ranked here.
Questions and answers
Which pharmaceuticals rank first by operating margin?
Royalty Pharma (65.6%), PTC Therapeutics (50.1%) and United Therapeutics (46.9%) are the top three of the 43 pharmaceuticals ranked by operating margin as of 18 Nov 2026, 12:51 UTC.
How many pharmaceuticals are in this ranking?
43 are ranked by operating margin. 18 more have no operating margin on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 43 pharmaceuticals ranked by operating margin have a combined market value of SAR 19.35T as of 18 Nov 2026, 12:51 UTC.
What does ranking by operating margin measure?
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Pharmaceuticals by operating margin”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=operating-margin
Underlying data: Yahoo Finance; SEC EDGAR.